HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Ceccherini Selected Research

Familial medullary thyroid carcinoma

10/2001The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Ceccherini Research Topics

Disease

6Hirschsprung Disease (Hirschsprung's Disease)
10/2023 - 01/2000
2Cryopyrin-Associated Periodic Syndromes
03/2011 - 03/2007
2Alexander Disease (Alexander's Disease)
06/2008 - 11/2007
2Thyroid Neoplasms (Thyroid Cancer)
03/2008 - 10/2001
2Multiple Endocrine Neoplasia Type 2a (MEN 2)
10/2001 - 01/2000
1Neutropenia
01/2024
1Rheumatoid Arthritis
01/2024
1Sjogren's Syndrome (Sjogren Syndrome)
01/2024
1Infections
01/2024
1Leukopenia
01/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2024
1Crohn Disease (Crohn's Disease)
10/2023
1Inflammation (Inflammations)
10/2023
1Thrombotic Thrombocytopenic Purpura
11/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2019
1Hip Dislocation
01/2018
1Acne Vulgaris
06/2017
1Necrosis
06/2017
1Hidradenitis Suppurativa
06/2017
1Pyoderma Gangrenosum
06/2017
1Fever (Fevers)
04/2011
1Hyperparathyroidism
03/2008
1Thyroid Nodule (Nodule, Thyroid)
03/2008
1Papillary Thyroid Cancer
03/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2007
1Hypoventilation
05/2004
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
09/2002
1Familial medullary thyroid carcinoma
10/2001
1type 4 Waardenburg syndrome
03/2001

Drug/Important Bio-Agent (IBA)

3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2003 - 01/2000
2Glial Fibrillary Acidic ProteinIBA
06/2008 - 11/2007
2NucleotidesIBA
09/2003 - 09/2000
1AntibodiesIBA
01/2024
13,3',4',5-tetrachlorosalicylanilideIBA
10/2023
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2019
1Ustekinumab (CNTO 1275)FDA Link
07/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1UbiquitinIBA
01/2018
1InterleukinsIBA
06/2017
1CytokinesIBA
06/2017
1Interleukin-17 ReceptorsIBA
06/2017
1DNA (Deoxyribonucleic Acid)IBA
04/2011
1Adenosine Triphosphate (ATP)IBA
03/2011
1Proteins (Proteins, Gene)FDA Link
03/2011
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2008
1Pentagastrin (Peptavlon)FDA Link
03/2008
1Small Heat-Shock ProteinsIBA
11/2007
1Protein AggregatesIBA
11/2007
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2007
1polyalanineIBA
05/2004
1Butyric Acid (Butanoic Acid)IBA
08/2003
1GoldIBA
09/2002
1AcetylcholinesteraseIBA
09/2002
1LigandsIBA
10/2001
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2001
1Endothelin-3 (Endothelin 3)IBA
03/2001
1Complementary DNA (cDNA)IBA
01/2000

Therapy/Procedure

2Therapeutics
01/2024 - 03/2007
1Lymph Node Excision (Lymph Node Dissection)
09/2002
1Thyroidectomy
09/2002